PAM
AKBA icon

Panagora Asset Management’s Akebia Therapeutics AKBA Stock Holding History

Panagora Asset Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Hold
236,111
– – ﹤0.01% 947
2025
Q4 		$380K Sell
236,111
-53
-0% -$111 ﹤0.01% 935
2025
Q3 		$645K Buy
236,164
+25,959
+12% +$86.4K ﹤0.01% 744
2025
Q2 		$765K Buy
+210,205
New +$578K ﹤0.01% 689
2022
Q3 		– Sell
-250,894
Closed -$89K – 1430
2022
Q2 		$89K Hold
250,894
– – ﹤0.01% 1444
2022
Q1 		$180K Buy
250,894
+233
+0.1% +$499 ﹤0.01% 1471
2021
Q4 		$566K Buy
250,661
+846
+0.3% +$2.31K ﹤0.01% 1171
2021
Q3 		$719K Buy
249,815
+179,229
+254% +$512K ﹤0.01% 1130
2021
Q2 		$268K Buy
+70,586
New +$238K ﹤0.01% 1568
2020
Q4 		– Sell
-30,487
Closed -$77K – 2799
2020
Q3 		$77K Buy
+30,487
New +$268K ﹤0.01% 1910
2018
Q2 		– Sell
-130,574
Closed -$1.24M – 2367
2018
Q1 		$1.24M Sell
130,574
-15,970
-11% -$223K ﹤0.01% 1078
2017
Q4 		$2.18M Buy
146,544
+116,418
+386% +$1.93M 0.01% 847
2017
Q3 		$593K Hold
30,126
– – ﹤0.01% 1303
2017
Q2 		$433K Buy
+30,126
New +$382K ﹤0.01% 1394
2016
Q1 		– Sell
-112,620
Closed -$1.46M – 2287
2015
Q4 		$1.46M Sell
112,620
-16,524
-13% -$169K 0.01% 922
2015
Q3 		$1.25M Buy
129,144
+24,987
+24% +$229K 0.01% 933
2015
Q2 		$1.07M Buy
104,157
+101,284
+3,525% +$864K 0.01% 1065
2015
Q1 		$32K Buy
+2,873
New +$30.6K ﹤0.01% 2149

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Panagora Asset Management's AKBA Position: Q1 2026 in Review

Panagora Asset Management held its Akebia Therapeutics (AKBA) position steady in Q1 2026 at 236,111 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Panagora Asset Management first reported a position in AKBA in Q1 2015 and has held it in 18 quarters since. The position peaked at $2.18M in Q4 2017. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Panagora Asset Management held 236,111 shares of Akebia Therapeutics worth $328K as of Q1 2026.
  • Panagora Asset Management left its Akebia Therapeutics share count unchanged in Q1 2026.
  • Akebia Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #947 holding.
  • Panagora Asset Management first reported a position in Akebia Therapeutics in Q1 2015 and has held it in 18 quarters since.
  • Panagora Asset Management's Akebia Therapeutics position peaked at $2.18M in Q4 2017.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.